Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Active Not Recruiting Phase 2 / 3 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0028768 (Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity)Active Not Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01810913Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck CancerTreatment